PVH
60
2
GIS
49
12
EFX
60
11
O
19
-12
ISRG
68
-3
SIG
54
2
AAL
59
-4
PDCO
74
-3
VTR
43
-3
AKAM
59
-2
DNB
58
2
GT
56
-2
PEP
42
-3
KO
44
-2
NDAQ
50
-6
RSG
62
-2
MCHP
43
6
FLR
46
-2
SBUX
32
-9
RF
47
3
PVH
60
2
GIS
49
12
EFX
60
11
O
19
-12
ISRG
68
-3
SIG
54
2
AAL
59
-4
PDCO
74
-3
VTR
43
-3
AKAM
59
-2
DNB
58
2
GT
56
-2
PEP
42
-3
KO
44
-2
NDAQ
50
-6
RSG
62
-2
MCHP
43
6
FLR
46
-2
SBUX
32
-9
RF
47
3
Financhill
Back

Kymera Therapeutics Stock Predictions

The dark truth about AI

Click here to learn more...
Sell
47

KYMR
Kymera Therapeutics

Last Price:
42.13
Seasonality Move:
17.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Kymera Therapeutics Stock Forecast

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 5.7% based on the past 4 years of stock performance.
  • Kymera Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Kymera Therapeutics Stock Undervalued?
    The current Kymera Therapeutics [KYMR] share price is $42.13. The Score for KYMR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 5.7% based on the past 4 years of stock performance.

Kymera Therapeutics Stock Rating

Sell
47
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics overpriced?

  • Kymera Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com

52-Week Data

52-Week High:
53.27
52-Week Low:
22.35

Prediction Charts

Market Cap:
2.73B
Price in USD:
42.13
Volume:
425.36K
Beta:
2.14

Technical Analysis

SMA50:
46.11
SMA100:
45.99
SMA200:
41.35
52-Wk Change:
73.37%

Stock Predictions

  • Is Kymera Therapeutics stock public?
    Yes, Kymera Therapeutics is a publicly traded company.
  • What is the Kymera Therapeutics stock quote today?
    The Kymera Therapeutics stock price is 42.13 USD today.
  • How to buy Kymera Therapeutics stock online?
    You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 45.41 47.02 48.29 45.38
Nov-26 46.92 45.98 47.57 44.75
Nov-27 46.05 46.86 47.73 46.05
Nov-29 47.00 46.85 47.09 46.31
Dec-2 48.92 47.74 49.35 47.65
Dec-3 47.37 46.91 47.76 46.03
Dec-4 46.60 46.02 47.36 45.22
Dec-5 45.71 44.08 46.37 43.66
Dec-6 44.02 46.67 47.42 44.02
Dec-9 46.70 43.65 47.41 43.23
Dec-10 43.81 45.05 45.38 43.06
Dec-11 45.75 45.02 46.66 44.93
Dec-12 44.90 42.17 45.05 41.03
Dec-13 41.81 42.13 43.02 40.95

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.